Product Description Analysis

Product Description analysis helps Regulatory Affairs Teams and Product & Engineering Teams evaluate device purpose, software signals, classification risk, and regulatory readiness before product-definition and regulatory scoping decisions.

What Regulatory Teams Can Decide

Is device scope clear?

Identify whether the Product Description defines intended use, product boundaries, operating context, core functionality, and responsible ownership, so teams can confirm review scope before design planning.

Where could classification risk appear?

Spot missing software details, weak interoperability assumptions, conflicting claims, outdated positioning, or traceability gaps before they create submission risk, approval delay, or development rework.

Can teams make scoping decisions?

Evaluate whether the Product Description provides enough regulatory evidence, technical detail, and standards references for Regulatory Affairs, Quality Assurance, and review teams to revise or escalate with confidence.

How Teams Use This Analysis

Regulatory Affairs Teams and Product & Engineering Teams use Product Description analysis to review product-definition content more consistently, catch classification risk earlier, and turn claims into decisions about regulatory scoping and design-input planning.

Device Risk Profiling

Surfaces misuse indicators, interoperability ambiguities, and safety concerns, giving quality reviewers earlier visibility into scoping risk before Product Description reaches design review.

Analyze Now

Intended Use Analysis

Maps device purpose and user contact signals into a clearer review position, helping regulatory teams understand intended-use boundaries before classification planning.

Analyze Now

Regulatory Pathway Mapping

Turns scattered product claims into structured findings, helping engineering teams prioritize revision needs, approval decisions, and escalation paths.

Analyze Now

AI/ML Device Regulatory Signal Analysis

Connects interoperability signals to regulatory scoping, giving teams a clearer basis for early submission planning and standards review.

Analyze Now

Design Input Completeness Signal

Organizes open architecture questions and reviewer notes into a practical follow-up path, so unresolved issues can be addressed before they become approval blockers.

Analyze Now

SaMD Classification Check

Checks whether software signals and regulatory references hold together, reducing the chance that teams rely on unsupported claims, inconsistent requirements, or outdated references.

Analyze Now

Key Product Description Insights

Automatan organizes Product Description evaluation into structured insights that help teams judge device coverage, regulatory alignment, scoping readiness, and the quality of the evidence behind classification decisions.

Document Name

Product description title is captured to maintain version traceability and avoid review confusion across regulatory and design-control cycles.

Try

Device Name

The device name provides a consistent anchor for insights, ensuring the analysis stays linked to the correct medical device, software product, or connected system.

Try

Device Overview

A structured summary of function, operating behavior, and workflow role gives teams immediate context without early scope misinterpretation.

Try

Device Purpose

Extracted purpose statements distinguish explicit commitments from implied intent, helping teams focus regulatory and design planning where it matters most.

Try

Product Configuration / Variants

Classification of base model versus variant clarifies which regulatory lens applies and directs early evidence collection.

Try

Principle of Operation

Flags energy-delivery, sensing, or algorithm-driven operation to highlight elevated safety scrutiny and prioritize assessment efforts.

Try

Physical Form Factor

Determines wearable or cloud-based status to guide classification assignment and control expectations.

Try

Components and Subsystems

Hardware versus software designation informs the correct design-control framework and subsystem classification logic.

Try

Materials of Construction

Patient-contact, fluid-contact, or non-contact material signals shape biocompatibility classification and monitoring priorities.

Try

Power Requirements

Interaction with mains power or external charging is identified, ensuring active devices or accessories are properly scoped.

Try

Consumables & Accessories

Disposable, reusable, or supporting component signals provide clarity on accessory scope and regulatory relevance.

Try

Sterilization State

Automated extraction of sterile status, such as sterile barrier or clean handling assumptions, informs packaging classification and validation requirements.

Try

Reuse Profile

Directional reuse-profile signals offer early insight for reprocessing and labeling planning.

Try

Device Class

Risk profile and intended use anchor classification reasoning and support FDA pathway mapping.

Try

Device Type

Identifies monitoring, diagnostic, or therapeutic roles to guide classification, standards mapping, and evidence expectations.

Try

User Contact Profile

Required patient-contact signals inform biocompatibility planning and safety evaluation design.

Try

Operating Environment

Deployment context, including hospital, home, cloud, or ambulatory settings, ensures use-related risk alignment with actual operating conditions.

Try

Claims & Clinical Assertions

Automatan compiles performance, workflow, connectivity, and compatibility claims to highlight potential regulatory focus areas.

Try

Regulatory Impact of Claims

Mapping claim implications guides prioritization of validation documentation and ensures evidence requirements are addressed early.

Try

Device Characteristics

Technical and operational traits, including autonomy, connectivity, and electromechanical behavior, affect verification planning and validation.

Try

Who Uses This Analysis

Product Description review pulls in several stakeholders at once. Each group needs a different cut of the same document, focused on the regulatory and technical questions closest to its mandate.

Regulatory Affairs Teams

Reads Product Description for classification signals, using the analysis to decide whether regulatory scoping needs revision.

Quality Assurance Leadership

Reviews design-control coverage, helping the team identify validation gaps before quality planning.

Product & Engineering Teams

Checks software evidence and subsystem references, making sure the document can support design review.

Startup Founders & Executive Teams

Uses the analysis to compare product claims against regulatory complexity, giving stakeholders a clearer basis for commercialization decisions.

Pre-Submission & Review Teams

Targets ambiguity signals and follow-up needs, turning the document review into a prioritized action list.

How PRD Analysis Connects to Your Regulatory Workflow

Automatan works inside the tools regulatory teams already use. Product Descriptions and supporting files can be imported from common document sources and turned into structured scoping intelligence without rebuilding the regulatory process.

Google Drive

Import documents directly from Google Drive so Automatan can extract classification signals and risk indicators from files already stored by the team.

Add AI Integration

Google Docs

Analyze Product Descriptions stored in Google Docs without moving files, enabling seamless extraction of regulatory insights within the existing workspace.

Add AI Integration

OneDrive

Access documents from OneDrive so teams in regulated environments can capture device signals directly from their repository.

Add AI Integration

Dropbox

Pull product descriptions from Dropbox to turn embedded software signals, claims, and interoperability signals into structured scoping intelligence inside Automatan.

Add AI Integration

Analyze Product Descriptions With Clearer Regulatory Evidence

Regulatory Affairs Teams and Quality Assurance Leadership need more than claims. Automatan helps teams analyze Product Descriptions for classification signals, scoping readiness, and follow-up actions, so every review leads to clearer regulatory decisions.